Public COA audit
GLP3-R · GLP-1 receptor agonist
Audited July 28, 2026
Several fields check out, but we found issues worth reviewing before you rely on this document.
- Legitimacy
- 72
- Confidence
- 85%
- Panels
- 3/7
- Purity (printed)
- 99.94%
Document details
Fields extracted from the certificate — not order or payment data.
- Batch / lot
- CRRT-15-0126-01
- Identity method
- HPLC with UV Detection Coupled with Mass Spectrometry (LCMS/MS)
- Sample date
- 2026-01-08
- Issue date
- 2026-01-11
7-panel checklist
Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.
3 of 7 present · 3 passed · 0 failed · 0 reported · 4 missing
Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.
Identity
Tested · passed · core
Compound identity confirmed (e.g. HPLC, mass spec).
GLP RT confirmed
Purity
Tested · passed · core
Reported purity percentage for the analyte.
99.94% average (Vial 1: 99.98%, Vial 2: 99.94%, Vial 3: 99.91%)
Heavy metals
Not on this COA
Lead, arsenic, cadmium, mercury, or similar limits.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Microbial
Not on this COA
Bioburden / microbial limits testing.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Endotoxin
Tested · passed · core
LAL or chromogenic endotoxin assay.
≤ 0.05 EU/mL (both replicates)
Sterility
Not on this COA
Sterility testing where applicable.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Residual solvent / water
Not on this COA
Residual solvents or water content limits.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
How to read this
Had data · good
Panel present with a pass (or clear acceptance).
Had data · bad
Panel present with a fail — a concrete quality signal.
Had data · unclear
Value reported without an explicit pass/fail mark.
Missing
Not on this certificate. Lowers thoroughness; you decide if that panel matters for your use case. PeptIQ’s score still factors coverage.
Findings
Evidence-linked observations from this audit.
High purity confirmed
Average purity of 99.94% across three vials is consistent with high-quality research peptide synthesis. Individual vial purities range from 99.91% to 99.98%.
Mass spec confirmation present
Mass spectrometry data shows [M+3H]3+ and [M+4H]4+ peaks consistent with peptide identification. Chromatogram shows single dominant peak.
Limited testing panels
Only purity, identity, and endotoxin testing performed. Missing heavy metals, microbial, sterility, and residual solvent/water analysis. This is common for basic research peptide COAs but limits comprehensive quality assessment.
Limited lab verification information
Freedom Diagnostics website and contact provided, but no accreditation information (ISO, GMP, etc.) visible on COA. Lab claims USA operation but no specific address or regulatory credentials shown.
Batch information complete
Lot number CRRT-15-0126-01 clearly stated with individual vial content measurements (15.53 mg, 15.02 mg, 15.27 mg).
Dates are reasonable
Received 2026-01-08, reported 2026-01-11 (3-day turnaround). Both dates are in the past relative to current date 2026-07-28.
Professional presentation
Document includes company branding, chromatogram, mass spec data, product photos, and chemist signature. Layout is organized and includes appropriate disclaimers for research use only.
PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.